Connect with us

Hi, what are you looking for?

Just In

WADA Prohibited List 2010 now published

Following its approval by the World Anti-Doping Agency’s Executive Committee on September 19, the 2010 List of Prohibited Substances and Methods is now available. This List will go into effect on January 1, 2010.

The 2010 List reflects the latest scientific advances and offers a number of noteworthy changes compared to the 2009 List:
Salbutamol
The status of salbutamol, a beta-2 agonist, will change. Therapeutic use of inhaled salbutamol will not be prohibited as of January 1, 2010. If the urinary concentration is above 1,000 nanograms per millilitre, there will be a presumption that the substance was not taken by inhalation and the athlete will have the burden to demonstrate through a controlled pharmacokinetic study that the level found in his urine was the result of therapeutic inhaled use.

Advertisement. Scroll to continue reading.

T/E Ratio Follow-Up
No further collections or analyses will be required in cases where the testosterone to epitestosterone (T/E) ratio is greater than 4 and an isotope ratio mass spectrometry (IRMS) test or any other reliable analytical method has not revealed evidence of exogenous administration of a prohibited substance.

Pseudoephedrine
Pseudoephedrine will be reintroduced to the List and will be prohibited above 150 micrograms per millilitre.

You can  consult the 2010 List, the 2010 Monitoring Program, a summary of modifications, a document providing additional information in regards to the reintroduction of pseudoephedrine, as well as a Q&A on major changes, by visiting the WADA website by clicking here

Advertisement. Scroll to continue reading.

Put together by a member of the World-Track and Field Website team members. This is usually done by an in house member with able assistance from someone or an agency reporting from outside.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

EDITOR'S PICKS